Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Documentation of Visual Inspection Results

Posted on By

SOP for Documentation of Visual Inspection Results

Recording Visual Inspection Outcomes

1) Purpose

The purpose of this SOP is to outline the procedure for documenting the results of visual inspections of capsules to ensure accuracy, traceability, and compliance with regulatory standards.

2) Scope

This SOP applies to all visual inspections conducted on capsules in the pharmaceutical manufacturing facility, from production through to final packaging.

3) Responsibilities

– QC personnel are responsible for recording the visual inspection results.
– Production supervisors must ensure that inspection documentation is completed accurately and in a timely manner.
– The QA department is responsible for reviewing and maintaining inspection documentation.

See also  SOP for Visual Inspection of Raw Materials: Inspection of Incoming Raw Materials for Signs of Contamination, Damage, or Inconsistencies Before Use

4) Procedure

1. Preparation for Documentation
1.1. Ensure availability of visual inspection forms and documentation tools.
1.2. Verify that forms are current and controlled versions.
2. Documentation Process
2.1. Upon completion of the visual inspection, immediately document the results.
2.2. Include the following details on the inspection form:
2.2.1. Batch number
2.2.2. Date and time of inspection
2.2.3. Name of inspector
2.2.4. Number of

capsules inspected
2.2.5. Number and type of defects observed
2.2.6. Acceptance or rejection decision
2.3. Use clear, legible handwriting or electronic entry as specified.
2.4. If defects are observed, record detailed descriptions and, if possible, attach photographic evidence.
3. Review and Approval
3.1. Submit the completed inspection form to the production supervisor for initial review.
3.2. The QA department will perform a final review and approval of the inspection documentation.
3.3. Any discrepancies or issues noted during the review should be addressed promptly.
4. Filing and Storage
4.1. File the approved visual inspection form in the batch record.
4.2. Store the batch records as per the company’s document retention policy.
5. Corrective Actions
5.1. If the batch is rejected, initiate a corrective action report.
5.2. Document all actions taken to rectify issues identified during visual inspection.

See also  SOP for Inkjet or Laser Coding: Instructions for Printing Batch Numbers, Expiry Dates, and Other Information on Capsules or Packaging

5) Abbreviations, if any

– QC: Quality Control
– QA: Quality Assurance

6) Documents, if any

– Visual Inspection Form
– Batch Record
– Corrective Action Report Form

7) Reference, if any

– FDA 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
– EMA Guidelines on Good Manufacturing Practice

8) SOP Version

Version 1.0

Capsule Formulation Tags:Capsule Batch Record, Capsule Blending, Capsule Cleaning Validation, Capsule Coating, Capsule Deviation Investigation, Capsule Dosage Form, Capsule Encapsulation, Capsule Equipment Qualification, Capsule Filling, Capsule Formulation SOP, Capsule Inspection Procedure, Capsule Integrity, Capsule Manufacturing, Capsule Mixing, Capsule Polishing, Capsule Production, Capsule Quality Control, Capsule Sampling, Capsule Shell Inspection, Capsule Weight Check

Post navigation

Previous Post: SOP for Criteria for Accepting or Rejecting Capsules Based on Visual Inspection
Next Post: SOP for Retention Samples Handling in Ointment Formulation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

English
 - 
en
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version